Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 600, pseudogene (RN7SL600P)

Target
RN7SL600P
Molecular classification
Other, pseudogene, noncoding RNA pseudogene
01

Overview

RNA, 7SL, cytoplasmic 600, pseudogene (RN7SL600P), is a pseudogene that is related to the functional 7SL RNA gene. The 7SL RNA is a noncoding RNA component of the signal recognition particle (SRP) complex, which is essential for co-translational targeting of secreted and membrane proteins to the endoplasmic reticulum in eukaryotic cells[3][1]. However, RN7SL600P itself is a pseudogene—a DNA sequence resembling a gene but typically nonfunctional due to mutations, truncations, or lack of expression—and does not encode an active RNA product or protein[2][5]. According to genomic analyses, there are hundreds of 7SL-like pseudogenes distributed in the human genome. These are byproducts of retrotransposition and other genomic events, often truncated at the 5' and/or 3' ends, and they do not contribute to the canonical SRP function or have known direct biological or disease associations[5]. They are generally considered non-functional genomic elements but may occasionally be transcribed; there is no evidence suggesting that RN7SL600P is a therapeutic or pharmacological target, nor is it involved in drug responses, disease roles, or considered as a biomarker. If you are interested in the functional 7SL RNA, it is a structural noncoding RNA playing a central role in protein secretion by forming the core of the SRP. Pseudogenes like RN7SL600P are primarily of genetic and evolutionary interest[1][5].

Other names
RN7SL600P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 600, pseudogene (RN7SL600P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 600, pseudogene (RN7SL600P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call